Douglas A. Rich
Net worth: 9 617 $ as of 2023-11-29
Profile
Douglas A.
Rich served as Senior Vice President-Operations at Kythera Biopharmaceuticals LLC.
He then worked as Vice President-Quality at Boehringer Ingelheim Corp.
from 2011 to 2014.
Later, he served as Senior Vice President-Operations at Unity Biotechnology, Inc. Mr. Rich is currently working as Chief Technical Officer at Applied Molecular Transport, Inc. from 2021 to 2023.
He completed his undergraduate degree from the University of Southern California and earned an MBA from Pepperdine University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-02-28 | 49,316 ( 0.12% ) | 9 617 $ | 2023-11-29 |
Former positions of Douglas A. Rich
| Companies | Position | End |
|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Chief Tech/Sci/R&D Officer | 2023-12-26 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 2013-12-31 |
| UNITY BIOTECHNOLOGY, INC. | Chief Operating Officer | - |
| KYTHERA BIOPHARMACEUTICALS INC | Chief Operating Officer | - |
Training of Douglas A. Rich
| University of Southern California | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- Douglas A. Rich